| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Adventrx Pharmaceuticals, Inc. > News item |
Adventrx files $100 million stock shelf
By Jennifer Chiou
New York, May 2 - Adventrx Pharmaceuticals, Inc. registered to sell $100 million of common stock in an S-3 with the Securities and Exchange Commission.
The company said proceeds will go toward research and development, clinical trials and general corporate purposes.
Based in San Diego, Adventrx is a biopharmaceutical research and development company that is focused on anticancer and antiviral treatments.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.